Putting patients in control
Our proven PURASORB® polymers are ideal resorbable excipients for controlled release drug delivery systems – enabling patients to control dosage over days, weeks, or months with a single injection.
PURASORB is safe, proven and effective.
Not only does the material benefit patients, but it also gives you maximum flexibility in formulation technologies - from extrusion and solvent processing to spray drying. All of which makes PURASORB the material of choice for the production of implants, microspheres, and gel depot systems.
Resorbable polymers for controlled release systems
When it comes to resorbable polymers for controlled release systems, our PURASORB solutions are available in PDLG (Poly DL-lactide/glycolide) and PDL (Poly DL-lactide) platforms.
Product not available in your region
This product is not available in the selected region.
If you want this product in your region, or find a suitable alternative, please contact us,
Corbion full year 2017 results
Corbion reported net sales of € 891.7 million in 2017, a decrease of 2.2% compared
Corbion in discussions to acquire Bunge's stake in SB Renewable Oils joint venture
Corbion nv (Euronext Amsterdam: CRBN) ("Corbion") announces it is in discussions with Bunge Limited (NYSE:
Corbion proposes re-appointment CFO Eddy Van Rhede van der Kloot
Corbion's Supervisory Board proposes to re-appoint CFO Eddy van Rhede van der Kloot for a
NYSCC suppliers day
New York, USA | This is an event for those involved in sourcing ingredients for cosmetics, health and beauty
AgriChem & Technology
Sao Paulo, Brazil | Advancing agrochemical formulations, R&D innovation and technology with crop protection. Learn from key agrochemical companies
Biobased Coatings Europe
Antwerp, Belgium | ACI’s Biobased Coatings Conference 2018 will bring together senior executives and experts from the coatings